Krystal Biotech Inc
NASDAQ:KRYS
| US |
|
Fubotv Inc
NYSE:FUBO
|
Media
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
| US |
|
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
| CN |
|
NIO Inc
NYSE:NIO
|
Automobiles
|
| US |
|
Fluor Corp
NYSE:FLR
|
Construction
|
| US |
|
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
| US |
|
TopBuild Corp
NYSE:BLD
|
Consumer products
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
Health Care
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
| US |
|
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
| US |
|
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
| US |
|
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
| US |
|
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
| US |
|
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
100.42
213.66
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Fubotv Inc
NYSE:FUBO
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
C
|
C3.ai Inc
NYSE:AI
|
US |
|
|
Uber Technologies Inc
NYSE:UBER
|
US |
|
|
NIO Inc
NYSE:NIO
|
CN |
|
|
Fluor Corp
NYSE:FLR
|
US |
|
|
Jacobs Engineering Group Inc
NYSE:J
|
US |
|
|
TopBuild Corp
NYSE:BLD
|
US |
|
|
Abbott Laboratories
NYSE:ABT
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
|
|
Occidental Petroleum Corp
NYSE:OXY
|
US |
|
|
Matrix Service Co
NASDAQ:MTRX
|
US |
|
|
Automatic Data Processing Inc
NASDAQ:ADP
|
US |
|
|
Qualcomm Inc
NASDAQ:QCOM
|
US |
|
|
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Krystal Biotech Inc
Wall Street
Price Targets
KRYS Price Targets Summary
Krystal Biotech Inc
According to Wall Street analysts, the average 1-year price target for
KRYS
is 211.93 USD
with a low forecast of 196.95 USD and a high forecast of 232.05 USD.
KRYS Last Price Targets
Krystal Biotech Inc
The latest public price target was made on Sep 11, 2024 by
Dae Gon Ha
from
Stifel Nicolaus
,
who expects
KRYS
stock to
rise by 18%
over the next 12 months.
You can read more about this price target by viewing
the article on TheFly.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Dae Gon Ha
Stifel Nicolaus
|
220
USD
Upside 18% |
2 months ago
Sep 11, 2024
|
Krystal Biotech price target raised to $220 from $204 at Stifel
TheFly
|
Alec Stranahan
Bank of America Securities
|
205
USD
Upside 10% |
2 months ago
Sep 2, 2024
|
Krystal Biotech price target raised to $205 from $195 at BofA
TheFly
|
Gavin Clark-Gartner
Evercore ISI
|
206
USD
Upside 10% |
3 months ago
Aug 12, 2024
|
Krystal Biotech price target raised to $206 from $201 at Evercore ISI
TheFly
|
|
Dae Gon Ha
Stifel Nicolaus
|
204
USD
Upside 9% |
7 months ago
Apr 15, 2024
|
Krystal Biotech (KRYS) PT Raised to $204 at Stifel
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KRYS's stock price target?
Price Target
211.93
USD
According to Wall Street analysts, the average 1-year price target for
KRYS
is 211.93 USD
with a low forecast of 196.95 USD and a high forecast of 232.05 USD.
What is Krystal Biotech Inc's Revenue forecast?
Projected CAGR
136%
The
compound annual growth rate
of Krystal Biotech Inc's revenue for the next 3 years is
136%.
What is Krystal Biotech Inc's Net Income forecast?
Projected CAGR
189%
The
compound annual growth rate
of Krystal Biotech Inc's net income for the next 3 years is
189%.
You don't have any saved screeners yet
